Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib.

Woyach JA, Jones D, Jurczak W, Robak T, Illés Á, Kater AP, Ghia P, Byrd JC, Seymour JF, Long S, Mohamed N, Benrashid S, Lai TH, De Jesus G, Lai R, de Bruin G, Rule S, Munugalavadla V

Open source

DOI: 10.1182/blood.2023023659
Published: 2024 Sep 5
Container: Blood
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2023023659,
  title = {Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib.},
  author = {Woyach JA and Jones D and Jurczak W and Robak T and Illés Á and Kater AP and Ghia P and Byrd JC and Seymour JF and Long S and Mohamed N and Benrashid S and Lai TH and De Jesus G and Lai R and de Bruin G and Rule S and Munugalavadla V},
  year = {2024},
  journal = {Blood},
  doi = {10.1182/blood.2023023659},
  url = {https://doi.org/10.1182/blood.2023023659}
}

RIS

TY  - JOUR
TI  - Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib.
AU  - Woyach JA
AU  - Jones D
AU  - Jurczak W
AU  - Robak T
AU  - Illés Á
AU  - Kater AP
AU  - Ghia P
AU  - Byrd JC
AU  - Seymour JF
AU  - Long S
AU  - Mohamed N
AU  - Benrashid S
AU  - Lai TH
AU  - De Jesus G
AU  - Lai R
AU  - de Bruin G
AU  - Rule S
AU  - Munugalavadla V
PY  - 2024
JO  - Blood
DO  - 10.1182/blood.2023023659
UR  - https://doi.org/10.1182/blood.2023023659
ER  -

APA

JA, W., D, J., W, J., T, R., Á, I., AP, K., P, G., JC, B., JF, S., S, L., N, M., S, B., TH, L., G, D. J., R, L., G, D. B., S, R., & V, M. (2024). Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib.. Blood. https://doi.org/10.1182/blood.2023023659

Source records

pubmed · retrieved 2026-11-10T18:02:51.563Z